Tyloxapol
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. (December 2009) |
 |
|
|---|---|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 25301-02-4  |
| ATC code | R05CA01 |
| PubChem | CID 71388 |
| DrugBank | DB06439 |
| ChemSpider | 11052515  |
| UNII | Y27PUL9H56 |
| KEGG | D03261 |
| ChEMBL | CHEMBL1201548 |
| Chemical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Mol. mass | variable |
 (what is this?) (verify) |
|
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
|
|||||||||||||||||||||
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
